wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35034703-558DE493-8736-4C79-9A88-9124E716B76D
Q35034703-558DE493-8736-4C79-9A88-9124E716B76D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35034703-558DE493-8736-4C79-9A88-9124E716B76D
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
P2860
Q35034703-558DE493-8736-4C79-9A88-9124E716B76D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35034703-558DE493-8736-4C79-9A88-9124E716B76D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
20631f2fb4cc847a18e61f887bedf085d7ca96de
P2860
Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors.